AIM: Individuals at clinical high risk for psychosis (CHR) exhibit neurocognitive deficits in multiple domains. The aim of this study is to investigate whether several components of neurocognition are predictive of conversion to psychosis. METHODS: Fifty-two CHR individuals were assessed with the Structured Interview for Psychosis Risk Syndromes and completed a battery of neurocognitive tests at baseline including measures of executive functioning, attention, working memory, processing speed and reaction time. Neurocognitive functioning at baseline was scored based on an external normative control group. Most subjects were followed for 2.5 years to determine conversion status. RESULTS: Significant differences in neurocognitive functioning between CHR individuals and the control group were present in all domains. Twenty-six per cent of the participants converted to psychosis within 9.8 (standard deviation = 8.0) months on average (median 9 months), but there were no significant differences in neurocognition converters and non-converters. CONCLUSIONS: Individuals at CHR have deficits in neurocognitive functioning, but such deficits do not appear to be related to conversion risk.
AIM: Individuals at clinical high risk for psychosis (CHR) exhibit neurocognitive deficits in multiple domains. The aim of this study is to investigate whether several components of neurocognition are predictive of conversion to psychosis. METHODS: Fifty-two CHR individuals were assessed with the Structured Interview for Psychosis Risk Syndromes and completed a battery of neurocognitive tests at baseline including measures of executive functioning, attention, working memory, processing speed and reaction time. Neurocognitive functioning at baseline was scored based on an external normative control group. Most subjects were followed for 2.5 years to determine conversion status. RESULTS: Significant differences in neurocognitive functioning between CHR individuals and the control group were present in all domains. Twenty-six per cent of the participants converted to psychosis within 9.8 (standard deviation = 8.0) months on average (median 9 months), but there were no significant differences in neurocognition converters and non-converters. CONCLUSIONS: Individuals at CHR have deficits in neurocognitive functioning, but such deficits do not appear to be related to conversion risk.
Authors: Paolo Fusar-Poli; Giacomo Deste; Renata Smieskova; Stefano Barlati; Alison R Yung; Oliver Howes; Rolf-Dieter Stieglitz; Antonio Vita; Philip McGuire; Stefan Borgwardt Journal: Arch Gen Psychiatry Date: 2012-06
Authors: Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods Journal: Schizophr Bull Date: 2003 Impact factor: 9.306
Authors: Todd Lencz; Christopher W Smith; Danielle McLaughlin; Andrea Auther; Emilie Nakayama; Lauren Hovey; Barbara A Cornblatt Journal: Biol Psychiatry Date: 2005-12-01 Impact factor: 13.382
Authors: Richard S E Keefe; Diana O Perkins; Hongbin Gu; Robert B Zipursky; Bruce K Christensen; Jeffery A Lieberman Journal: Schizophr Res Date: 2006-08-22 Impact factor: 4.939
Authors: Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung Journal: JAMA Psychiatry Date: 2013-01 Impact factor: 21.596
Authors: Ricardo E Carrión; Terry E Goldberg; Danielle McLaughlin; Andrea M Auther; Christoph U Correll; Barbara A Cornblatt Journal: Am J Psychiatry Date: 2011-05-02 Impact factor: 18.112
Authors: Caroline Ranem Mohn-Haugen; Christine Mohn; Frank Larøi; Charlotte M Teigset; Merete Glenne Øie; Bjørn Rishovd Rund Journal: Schizophr Res Cogn Date: 2022-03-01